Io Biotech Stock Investor Sentiment
| IOBT Stock | USD 0.29 0.03 9.38% |
Slightly above 51% of IO Biotech's private investors are presently thinking to get in. The analysis of the overall investor sentiment regarding IO Biotech suggests that some traders are interested. IO Biotech's investing sentiment can be driven by a variety of factors including economic data, IO Biotech's earnings reports, geopolitical events, and overall market trends.
Comfort Level 51
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use IO Biotech's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward IO Biotech.
News SentimentBearish | Hype SentimentBearish | Insider SentimentAcquiring |
IOBT Historical Sentiment
Although IO Biotech's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding IOBT, such as negative comments on social media and news outlets, may cause fear in the market and push IO Biotech's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of IOBT.
IO Biotech Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards IO Biotech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
IO Biotech Historical Investor Sentiment
Investor biases related to IO Biotech's public news can be used to forecast risks associated with an investment in IOBT. The trend in average sentiment can be used to explain how an investor holding IOBT can time the market purely based on public headlines and social activities around IO Biotech. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
IO Biotech's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for IO Biotech and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average IO Biotech news discussions. The higher the estimate score, the more favorable the investor's outlook on IO Biotech.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of IO Biotech's Stock prices. Below is the latest headlines and news related to IO Biotech Stock. Current markets are strongly bullish. About 74% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about IO Biotech that are available to investors today. This information is accessible both publicly - through IO Biotech's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of IOBT-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of IO Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of IO Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to IO Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive IO Biotech alpha.
IOBT Largest EPS Surprises
Earnings surprises can significantly impact IO Biotech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-14 | 2024-03-31 | -0.36 | -0.3 | 0.06 | 16 | ||
2024-11-12 | 2024-09-30 | -0.29 | -0.36 | -0.07 | 24 | ||
2023-08-11 | 2023-06-30 | -0.66 | -0.74 | -0.08 | 12 | ||
2025-11-07 | 2025-09-30 | -0.345 | -0.2498 | 0.0952 | 27 | ||
2023-05-11 | 2023-03-31 | -0.7 | -0.59 | 0.11 | 15 | ||
2023-03-14 | 2022-12-31 | -0.59 | -0.7 | -0.11 | 18 |
There is far too much social signal, news, headlines, and media speculation about IO Biotech that are available to investors today. This information is accessible both publicly - through IO Biotech's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of IOBT-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of IO Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of IO Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to IO Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive IO Biotech alpha.
IO Biotech Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | IO Biotech Presents at Jefferies Global Healthcare Conference - TipRanks | 11/18/2025 |
2 | IO Biotech Announces Resignation of Chief Accounting Officer - TipRanks | 11/21/2025 |
3 | IO Biotech Announces Participation in Upcoming December Investor Conferences | 11/26/2025 |
4 | IO Biotech Receives Nasdaq Notice for Bid Price Noncompliance - TipRanks | 12/19/2025 |
5 | IO Biotech receives Nasdaq notice for bid price noncompliance - MSN | 01/06/2026 |
6 | Acquisition by Smith David V of 35144 shares of IO Biotech at 1.5 subject to Rule 16b-3 | 01/07/2026 |
7 | What margin trends mean for IO Biotech Inc. stock - Market Growth Report Weekly Setup with High ROI Potential - moha.gov.vn | 01/13/2026 |
8 | IOBT IO Biotech, Inc. 0.47 on 22 Jan 2026 active intraday mover for traders - Meyka | 01/22/2026 |
9 | IO Biotech Provides Corporate Update | 01/30/2026 |
Additional Tools for IOBT Stock Analysis
When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.